J Korean Ophthalmol Soc.  2004 Sep;45(9):1487-1495.

Intravitreal Triamcinolone Injection for Uveitic Cystoid Macular Edema

Affiliations
  • 1The Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea. sunglee@yumc.yonsei.ac.kr

Abstract

PURPOSE
To investigate the results of intravitreal injection of triamcinolone acetonide (TA) for the treatment of chronic uveitic cystoid macular edema (CME). METHODS: Six patients, 8 eyes with refractory uveitic CME were included in the study. Four milligrams of TA was injected into the vitreous cavity. The clinical outcome and complication were reviewed, retrospectively. RESULTS: Ten intravitreal injections of TA were performed, and the mean follow-up duration was 10.4 months (6~19 months). Foveal retinal thickness diminished and CME improved anatomically in 7 (88%) eyes. Visual acuity improved by 1.75 lines of the Snellen chart in 6 (75%) eyes, and the time to improvement varied from 1 week to 8 months. Inflammation decreased in all eyes and there was symptomatic improvement in 6 (75%) eyes. CME recurred in 3 (38%) eyes at 4 to 16 weeks and re-treatments were performed in 2 eyes. Intraocular pressure increased in 3 eyes and one eye needed additional filtration surgery. Cataract worsened in one eye. CONCLUSIONS: Intravitreal triamcinolone injection effectively induced anatomic and symptomatic resolution, and decreased inflammation in uveitic CME patients. Nevertheless, the visual improvement was modest, and consideration for recurrence and complication is necessary.

Keyword

Cystoid macular edema; Foveal retinal thickness; Triamcinolone acetonide; Uveitis

MeSH Terms

Cataract
Filtering Surgery
Follow-Up Studies
Humans
Inflammation
Intraocular Pressure
Intravitreal Injections
Macular Edema*
Recurrence
Retinaldehyde
Retrospective Studies
Triamcinolone Acetonide
Triamcinolone*
Uveitis
Visual Acuity
Retinaldehyde
Triamcinolone
Triamcinolone Acetonide
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr